Furthermore, treatment of tumour cells obtained from three patients with AML at diagnosis using combination of AraC and MUC1 inhibitor GO‐203, led to a similar strong synergistic response (CI 0.28) as demonstrated in representative Figure 6E. This evidence concerns the gene MUC1 and acute myeloid leukemia.